Mitotane
CHEBI:CHEBI_6954
Chemical Information
- Molecular Formula
- C14H10Cl4
- Molecular Mass
- 320.041
- Charge
- 0
- SMILES
- C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
- InChI
- InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H
- InChIKey
- JWBOIMRXGHLCPP-UHFFFAOYSA-N
Alternative Names
- chloditan
- chlodithane
- lysodren
- Lysodren (TN)
- mitotan
- Mitotane
- opeprim
Drug Classification
-
diarylmethaneView Class →
CHEBI:51614
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:6954
- DRON_00010000
- 7004
- oboInOwl#hasDbXref
- LINCS:LSM-1451
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:6954
- active_ingredient_strength
- 1 kg/kg
- nui
- N0000185506
- pharm_class_moa
- Cytochrome P450 3A4 Inducers [MoA]
- pharm_class
- Cytochrome P450 3A4 Inducers [MoA]
- package_marketing_start_date
- 02-JUN-20
- active_ingredient_name
- MITOTANE
- manufacturer_name
- HRA Pharma Rare Diseases
- unii
- 78E4J5IB5J
- spl_set_id
- f0cd76e9-460c-450e-b094-172e636f340a
- package_description
- 500 g in 1 CONTAINER (49452-4786-5)
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 7004
- oboInOwl#hasDbXref
- LINCS:LSM-1451
- oboInOwl#id
- CHEBI:6954
- oboInOwl#hasAlternativeId
- CHEBI:91626
- generic_name
- mitotane
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- listing_expiration_date
- 20241231
- route
- ORAL
- dosage_form
- POWDER
- marketing_start_date
- 20100519
- labeler_name
- HRA Pharma Rare Diseases
- product_ndc
- 14799-2009
- spl_id
- 44c9e922-1626-4103-be4b-dee965befa1b
- package_ndc
- 14799-2009-5
- brand_name
- Lysodren
- brand_name_base
- Lysodren
- application_number
- NDA016885
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#2_STAR
- has_treatment
- http://purl.obolibrary.org/obo/DOID_0070547
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect32978
- owl#annotatedSource
- t276766
- owl#someValuesFrom
- t2915862